ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,144Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 185

$1.06M Total Retail Price of All Prescriptions

Rank: 11 out of 185

1,509 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 1,509 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 1,509 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 5,694 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$116 was the average price of a prescription from this provider, compared to $241 among peers.

Prescriptions per Patient

6 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
AMLODIPINE BESYLATE 306 233 1 49
GABAPENTIN 251 136 2 1
LISINOPRIL 237 172 3 55
METOPROLOL TARTRATE 228 156 4 58
FUROSEMIDE 215 144 5 61
HYDROCHLOROTHIAZIDE 177 135 6 72
ATORVASTATIN CALCIUM 167 121 7 65
SIMVASTATIN 165 119 8 52
TOPIRAMATE 159 35 9 6
OXYCODONE-ACETAMINOPHEN 150 73 S2 10 40
OMEPRAZOLE 149 90 11 54
PRAVASTATIN SODIUM 137 102 12 70
LEVOTHYROXINE SODIUM 133 95 13 48
CARVEDILOL 126 100 14 68
LEVETIRACETAM 124 28 15 3
HYDROCODONE-ACETAMINOPHEN 121 54 S3 16 8
DONEPEZIL HCL 108 79 17 4
OXYCODONE HCL 97 44 S2 18 28
METFORMIN HCL 81 58 19 95
METOPROLOL SUCCINATE 79 47 20 66
FOSINOPRIL SODIUM 77 56 21 98
TRAMADOL HCL 75 25 22 24
WARFARIN SODIUM 74 67 23 101
CYMBALTA 72 25 24 11
NEXIUM 69 38 25 107
CITALOPRAM HBR 67 26 26 19
NAMENDA 67 67 26 5
PREDNISONE 66 38 28 71
LANTUS 65 43 29 110
TRAZODONE HCL 63 46 30 35
LUMIGAN 62 52 31 113
ALLOPURINOL 59 55 32 117
AMITRIPTYLINE HCL 58 27 R 33 21
CLOPIDOGREL 57 33 34 37
TIMOLOL MALEATE 56 50 35 123
ATENOLOL 56 44 35 123
LATANOPROST 54 45 37 127
SPIRIVA 53 29 38 128
PLAVIX 52 43 39 50
PROAIR HFA 51 35 40 129
ADVAIR DISKUS 51 35 40 129
SPIRONOLACTONE 51 36 40 129
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.